Calyx Bio-Ventures Inc.
TSX VENTURE : CYX

Calyx Bio-Ventures Inc.

March 16, 2015 08:00 ET

Calyx Subsidiary Cannigistics Enters into Memorandum of Understanding for Clinical Trials Software Platform

VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 16, 2015) - Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) ("Calyx" or "the Company") is pleased to announce that its wholly-owned subsidiary, Cannigistics Agri-Solutions Corp. ("Cannigistics"), has entered into a memorandum of understanding ("MOU") with a third party with respect to the implementation of a clinical trials software platform.

The MOU has been signed with a well respected group of Canadian medical specialists that require a secure platform to gather, store, analyze, and report on the results of the trials. The Cannigistics' software and information technology platform will be utilized to create an environment that will allow the physicians to conduct the trials with confidence. Data can be used, parsed, sorted, analyzed and made anonymous so that other specialists can also have access to the results with no concerns over patient confidentiality.

The resulting platform will be a tailor made solution licensed on a non-exclusive basis, allowing Cannigistics to license the resulting platform to any other parties conducting clinical trials with the ability to customize to their specific needs. This will be a new area of deployment for the Cannigistics software platform, and potentially opens up a new market in the near term.

"We are pleased to have entered into an agreement with a respected group of healthcare practitioners to provide an end-to-end technical solution, from application design to deployment and management" said Roger Forde, President and CEO of Cannigistics. "This further validates the strategy that Cannigistics has established to provide technology solutions addressing key requirements of companies operating in the health sciences sector. We are looking forward to becoming a significant participant in the sector."

About Calyx

Calyx's wholly-owned subsidiary, Cannigistics Agri-Solutions Corp, is a software development company that has created a software platform tailored to advanced indoor agriculture. The Cannigistics software platform is designed to enhance the efficiency and effectiveness of indoor agricultural operations, and positions Cannigistics to be the industry leader in agri-software solutions by providing businesses with advanced controls over all aspects of their operations. Additionally, Calyx owns a portfolio of proprietary intellectual property with applications in crop enhancement. Calyx also has an approximate shareholding of 19% in Agrisoma Biosciences Inc., a company which is commercializing carinata, a non-food energy feedstock crop, for biofuel production.

For further information about Calyx, please visit www.calyxbio.com.

For additional information about Cannigistics, please visit www.cannigistics.com.

ON BEHALF OF THE BOARD OF DIRECTORS

Don Konantz, Director, President and Chief Executive Officer

Forward-Looking Statements: This document contains certain forward-looking statements concerning Calyx, as well as other expectations, plans, goals, objectives, information or statements about future events, conditions, or performance that may constitute "forward-looking statements" or "forward-looking information" under applicable securities legislation. Such statements or information involve substantial known and unknown risks and uncertainties, certain of which are beyond Calyx's control. Such forward-looking statements or information are based on a number of assumptions, which may prove to be incorrect.

Although Calyx believes that the expectations reflected in such forward-looking statements or information are reasonable, undue reliance should not be placed on forward-looking statements because Calyx can give no assurance that such expectations will prove to be correct. Forward-looking statements or information are based on current expectations, estimates and projections that involve a number of risks and uncertainties which could cause actual results to differ materially from those anticipated by Calyx and described in the forward-looking statements or information.

The forward-looking statements or information contained in this news release are made as of the date hereof and Calyx undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise unless so required by applicable securities laws or the TSX Venture Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information